Search
    Skip to main content
    Advertisement

    "FSGS"

    Search all headlines
    In the last 7 days
    A Look At Travere Therapeutics (TVTX) Valuation After FDA Expands FILSPARI Approval For FSGS Simply Wall St10:49 18-Apr-26
    FDA Approves Sparsentan as First FSGS Treatment Medpage Today22:28 14-Apr-26
    Travere’s Filspari approved for rare kidney disease Fsgs BioWorld22:22 14-Apr-26
    FDA Approves Sparsentan, Making It the First and Only Treatment for FSGS Rare Disease Advisor18:52 14-Apr-26
    Travere Therapeutics Stock Soars 33% After FDA Approves FILSPARI as First Drug for Rare Kidney… International Business Times - AU Edition14:54 14-Apr-26
    Travere’s Filspari Is First Drug Approved For FSGS Scrip Pharma Intelligence12:52 14-Apr-26
    Travere Therapeutics gains FDA approval for sparsentan in FSGS Pharmaceutical Business Review11:45 14-Apr-26
    Travere claims first FDA OK in rare kidney disease FSGS pharmaphorum11:06 14-Apr-26
    Travere Wins Full FDA Approval For Filspari In Fsgs RTT News09:08 14-Apr-26
    In the last month
    Despite uncertainties, Travere’s Filspari emerges as first FDA-approved FSGS treatment FiercePharma23:37 13-Apr-26
    Travere Therapeutics Announces Full FDA Approval of Filspari® (sparsentan), the First and Only… Business Wire (Press Release)23:16 13-Apr-26
    Rituximab Regimen Matches High-Dose Steroids While Reducing Toxicity in FSGS Rare Disease Advisor18:19 7-Apr-26
    Case Report: Rituximab Achieves Durable Remission in Adult FSGS Rare Disease Advisor02:22 4-Apr-26
    Genetic Testing Refines FSGS Diagnosis in UMOD Variant Case Rare Disease Advisor20:27 3-Apr-26
    view more headlines
    18 Apr 10:49
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.